Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07341893
NA
Sacubitril-valsartan in Patients With Heart Failure.
Sponsor: Damanhour University
View on ClinicalTrials.gov
Summary
The aim of this study is to evaluate the safety and efficacy of Sacubitril -Valsartan in patients with heart failure.
Official title: Clinical Study Evaluating Efficacy and Safety Sacubitril-valsartan in Patients With Heart Failure.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-08-01
Completion Date
2026-03-30
Last Updated
2026-01-14
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sacubitril-valsartan
patients (n=30) will be given Sacubitril-valsartan 50 mg twice daily.
DRUG
standard treatment of heart failure
Control group (n=30) on standard treatment of heart failure.
Locations (1)
Damanhur Medical National Institute
Damanhūr, Elbehairah, Egypt